(Reuters) - Newmont has applied for a voluntary delisting of its common shares from the Toronto Stock Exchange due to low trading volumes, the world's top gold miner said on Wednesday. The move, expected to be effective on or about the close of trading September 24, is likely to improve the administrative efficiency and reduce costs. Bloomberg News reported in August that Newmont has set a target of reducing costs by $300 per ounce, which could lead to thousands of layoffs. Last year, the miner had anno ...

Financial Performance - Consolidated revenue for Q2 2025 was approximately $13.2 million, down from approximately $17.0 million in Q2 2024, primarily due to a decline in Healthcare Operations [5] - The gross profit margin decreased to approximately 21.8% from 34.5% year-over-year, with the Healthcare segment's margin dropping to 19.9% from 35.2% [5] - Operating expenses decreased significantly to approximately $4.7 million from $16.8 million in the prior year, aided by a reduction in non-recurring expenses and ongoing cost-cutting measures [5] - Net loss attributable to common shareholders decreased by 66% to approximately $1.8 million, or ($0.07) per diluted share, compared to a net loss of approximately $5.3 million, or ($0.28) per diluted share in Q2 2024 [5][13] Business Operations - The company is focusing on improving its Healthcare Operations through various initiatives aimed at enhancing customer attraction and retention [2] - Significant efforts are being made to implement cost-reduction strategies and operational efficiency improvements, with expected annual savings exceeding $1.0 million [5][6] - The company is exploring new business expansion opportunities in higher margin and higher growth segments of the Healthcare spectrum [2] E-Commerce Growth - E-Commerce revenue continues to grow, driven by record levels of recurring airtime contracts and hardware sales [11] - The company is expanding its connectivity products and services, particularly in Europe, and is working to secure new contracts [11] - Sales of OPKO-branded health and wellness products on Alibaba's Tmall Global in China are increasing, despite inventory limitations [11] Organizational Developments - Following the passing of the former CEO, the company has identified three primary objectives: enhancing operational efficiency, ensuring capable leadership, and committing to prudent investments for growth [6] - The company is actively recruiting dedicated sales professionals to focus on opportunities in the 340B and Long-Term Care segments [5]

Financial Performance - AstroNova achieved a 14.4% revenue increase in Q1 FY2026, driven by double-digit growth in both segments[10] - Product Identification revenue grew by 13.8% year-over-year to $26.3 million[22] - Aerospace revenue increased by 16.8% year-over-year to $11.4 million[23] - Adjusted EBITDA margin increased to 8.3% in Q1 FY26[45] - The company reaffirms FY2026 revenue guidance to range from $160 million to $165 million, with an adjusted EBITDA margin expected to expand to 8.5% to 9.5%[15, 55] Strategic Initiatives and Cost Reduction - AstroNova is implementing cost reduction actions, with $1.9 million of annualized savings achieved in Q1 FY26 and a total of $3 million expected in the first half of FY2026[15] - The company reduced headcount by 10% and simplified the leadership structure[7] - Three Product ID products were launched, with six more in development[12] Orders and Backlog - Aerospace orders increased from $25.5 million in Q1 FY25 to $31.6 million in Q1 FY26[18] - Product Identification backlog increased from $33.1 million in Q1 FY25 to $34.9 million in Q1 FY26[18] Aerospace Sector - 42% of total unit shipments in Aerospace constituted ToughWriter shipments, with a target of over 80% by year-end[28] - The company renewed a $10 million multi-year Aerospace defense contract[13]